Compile Data Set for Download or QSAR
Report error Found 2 Enz. Inhib. hit(s) with all data for entry = 10727
TargetVascular endothelial growth factor receptor 2(Human)
Kala Pharmaceuticals

US Patent
LigandPNGBDBM562108(US11401260, Compound 1 | 7-(3-[4,4-bis(hydroxymeth...)
Affinity DataKd:  0.380nMAssay Description:A competition binding assay, was used to measure the ability of a compound to compete for binding of an immobilized adenosine triphosphate (ATP) site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

TargetIsoform 2 of Proto-oncogene tyrosine-protein kinase receptor Ret(Human)
Kala Pharmaceuticals

US Patent
LigandPNGBDBM562108(US11401260, Compound 1 | 7-(3-[4,4-bis(hydroxymeth...)
Affinity DataKd:  3.90nMAssay Description:A competition binding assay, was used to measure the ability of a compound to compete for binding of an immobilized adenosine triphosphate (ATP) site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent